Barely Significant
← all excerpts

Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis.

Pharmaceuticals (Basel) · 2023 · PMC10058541 · PMID 36986565

1
hedged sentence
closest p
boldest claim

The sentences

an increasing trendno p-value reported
Taking into account the healthcare facilities used from the 5th to the 2nd year before the first JAKi dispensation, we observed an increasing trend over the years, but in the year before the JAKi introduction, the ED accesses and the RA visits decreased with the exception of the hospitalizations that remained constant.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.